physIQ

physIQ delivers personalized medical predictions that can vastly improve patient outcomes.

[physIQ @PhysIQ]

Do you have questions about #wearables in #ClinicalTrials? Not sure who to ask? Check out our on-demand #webinar where three experts dispelled the myths and revealed the realities so you can utilize the power of continuous data in your next trial.
https://t.co/YITAdJ9xCR

[physIQ @PhysIQ]

Taking measurements exclusively in a clinical setting provides a limited view of the patient. #RemotePatientMonitoring can offer clinicians an individual's baseline so they are compared to themselves, not only to the average of all humans. via @medcitynews
https://t.co/CvThdnhezL

[physIQ @PhysIQ]

@physIQ's novel approach to estimating VO2Max using #wearable biosensors can be generated using data captured during daily activities, enabling remote assessment at higher convenience than by in-clinic tests, such as the CPET, and the less accurate, 6MWT.
https://t.co/SRn34txhVe

[physIQ @PhysIQ]

Barriers to access for #ImmunoOncology therapies are threatening the promise of these lifesaving treatments. Check out this on-demand #webinar where experts from @MoffittNews, @OncoBay & @physIQ discuss strategies to expand access to trials and treatments.
https://t.co/POLLGxgh95

[physIQ @PhysIQ]

Do you have questions about #wearables in #ClinicalTrials? Not sure who to ask? Check out our on-demand #webinar where three experts dispelled the myths and revealed the realities so you can utilize the power of continuous data in your next trial.
https://t.co/3lFQwuwsqS

[physIQ @PhysIQ]

How does @physIQ deliver personalized medical predictions that vastly improve patient outcomes? It starts with the difference between "normal" and "average."
Want to learn more? Check out the Power of the physIQ Digital Twin.
https://t.co/MHztz76hmN

[physIQ @PhysIQ]

@OncoBay and @physIQ partnered to make #ImmunoOncology trials more accessible for patients through a predict-to-prevent #SafetyMonitoring solution. This on-demand #webinar explores how this improved immuno-oncology trial model can have positive results.
https://t.co/mCHC9E9CgX

[physIQ @PhysIQ]

John Varaklis was recently interviewed about @physIQ's #MachineLearning based algorithms for early detection of physiological conditions to inform both #ClinicalCare and clinical #DrugDevelopment.
Read the full interview here: https://t.co/DwyWRlUjfU

[physIQ @PhysIQ]

physIQ's Intrepid Partner Program enables the #LifeSciences solutions ecosystem to deliver next generation near real time patient insights powered by high-fidelity medical grade biosensor data streams, providing its partners a distinct advantage
Learn more https://t.co/uo9tafsUFH

[physIQ @PhysIQ]

@physIQ's eVO2Max estimates maximum oxygen utilization using #wearable biosensors during daily activities. This approach enables remote assessment at higher frequency and convenience compared to in-clinic tests of cardiopulmonary functional capacity.
https://t.co/kCWUYPOrCi

[physIQ @PhysIQ]

#SCOPE2023 is in full swing! Schedule time with the @physIQ experts to learn how to move from efficacy to effectiveness using #AI-based #digitalbiomarkers that allow you to make better decisions and produce better outcomes.
Schedule your meeting here: https://t.co/br0RX4cB1A

[physIQ @PhysIQ]

Barriers to access for #ImmunoOncology therapies are threatening the promise of these lifesaving treatments. Check out this on-demand #webinar where experts from @MoffittNews, @OncoBay & @physIQ discuss strategies to expand access to trials and treatments.
https://t.co/F5VvovjW6i

[physIQ @PhysIQ]

98.6 degrees, 120 over 80, 72 beats per minute, vital signs we have known since our first visit to the doctor. These measurable baselines serve as indicators of concern when they rise or fall. But with modern #technology, we can do better.
https://t.co/8tspBiMxAK

[physIQ @PhysIQ]

Attending #SCOPE2023? Schedule time with the @physIQ experts to learn how to move from efficacy to effectiveness using #AI-based #digitalbiomarkers that allow you to make better decisions and produce better outcomes. Schedule your meeting here: https://t.co/61Y76Chuwu

[physIQ @PhysIQ]

Miss the #webinar yesterday? Fear not, the Strategies to Expand Access to Immuno-Oncology Trials and Treatments webinar with experts from @MoffittNews, @OncoBay and @physIQ is now On Demand!
Access the video here: https://t.co/nuDzW0B0ff
#Webinars #Oncology #ImmunoOncology

[physIQ @PhysIQ]

See how @physIQ's Digital Twin makes CAR-T Therapy safer, less expensive, and more accessible.
https://t.co/weuxY7cuwa

#Oncology #CARTtherapy #ImmunoOncology #Cancer #PersonalizedMedicine #SafetyMonitoring #AI #Pharma #LifeSciences

[physIQ @PhysIQ]

A recent study found that #telehealth saves time and money for patients which could improve care delivery & may reduce financial toxicity of cancer care, one of the challenges identified by @MoffittNews and @_DiMeSociety. Join the #webinar to learn more: https://t.co/eTe8uzkGnY

[physIQ @PhysIQ]

Barriers to access for #ImmunoOncology therapies like CAR-T are threatening the promise of these lifesaving treatments. Join experts from @MoffittNews, @OncoBay & @physIQ as they discuss strategies to expand access to Immuno-Oncology trials & treatments.
https://t.co/MS9phvsJau

[physIQ @PhysIQ]

"Consider all systems when someone stands up and walks up the stairs. How does the heart respond to the number of steps taken, what is the compensation for using particular muscles? These are all connected."
https://t.co/23vTAbP8kY

[physIQ @PhysIQ]

Attending #SCOPE2023? Schedule time with @physIQ experts to learn how #AI-based #digitalbiomarkers can deliver actionable clinical insights, allowing you to make better decisions and produce better outcomes. Schedule your meeting here: https://t.co/D6yEuk3Ur3